View in EDS HTML Full Text PDF Full Text

Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).

Saved in:
Bibliographic Details
Title: Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Authors: Velicki, Lazar1,2 (AUTHOR), Popovic, Dejana3 (AUTHOR), Okwose, Nduka C.4,5 (AUTHOR), Preveden, Andrej1,2 (AUTHOR), Tesic, Milorad3 (AUTHOR), Tafelmeier, Maria6 (AUTHOR), Charman, Sarah J.4 (AUTHOR), Barlocco, Fausto7 (AUTHOR), MacGowan, Guy A.4,8 (AUTHOR), Seferovic, Petar M.3 (AUTHOR), Filipovic, Nenad9,10 (AUTHOR), Ristic, Arsen3 (AUTHOR), Olivotto, Iacopo7 (AUTHOR), Maier, Lars S.6 (AUTHOR), Jakovljevic, Djordje G.4,5,8 (AUTHOR) djordje.jakovljevic@coventry.ac.uk, Redzek, Aleksandar (AUTHOR), Bjelobrk, Marija (AUTHOR), Ilic, Aleksandra (AUTHOR), Golubovic, Miodrag (AUTHOR), Miljkovic, Tatjana (AUTHOR)
Source: European Journal of Heart Failure. Jun2024, Vol. 26 Issue 6, p1361-1368. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.3291